NL-OMON42200已完成不适用
Glucerna in Critically ill Patients (GluCip trial): Investigating the glycaemic effects of a reduced-carbohydrate, modified-fat, fiber-containing enteral formula (Glucerna®) in critically ill patients. - GluCip Trial
Onze Lieve Vrouwe Gasthuis0 个研究点目标入组 90 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 90
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Age >= 18 years
- •Patients with an anticipated stay of at least 24 hours of admission to the intensive care
- •Expected to receive enteral feeding for at least 72 hours
- •Indication for glucose regulation with insulin (according to the current glucose treatment protocol)
- •Patient or surrogate understands and signs informed consent document
排除标准
- •Patients with pre-existing contraindications to enteral feeding or to placement of a CGM system
- •Patients previously randomised into the GluCip trial
- •Any disease or condition which the investigator or treating physician feels would interfere with the trial or the safety of the patient.
研究者
相似试验
已完成
不适用
The Glycaemic Effects of Glucerna® in Critically Ill Patients.Disorder of Glucose RegulationNCT02594865PHJ van der Voort100
终止
2 期
iberal blood glucose control in critically ill patients with pre-existing type 2 diabetes.Critical illnessMetabolic and Endocrine - DiabetesType 2 DiabetesACTRN12616001135404Royal Adelaide Hospital436
招募中
不适用
Effect of critical illness on blood flow to the gastrointestinal tract during feeding and the absorption of sugar in older patientsSuperior Mesenteric Artery Blood Flow in older Critically ill patientsGlucose Absorption in older Critically ill patientsDiet and Nutrition - Other diet and nutrition disordersACTRN12611000218998Jennifer Sim30
已完成
不适用
Usability of Blood Glucose Control With the Space TGC System in Medical ICU PatientsCritical IllnessNCT01164449B. Braun Melsungen AG20
已完成
不适用
Iranian Intensive Care Unit (ICU) Glutamine StudyTrauma Patients in ICUNCT01219608Shahid Beheshti University of Medical Sciences60